So if we apply the same PE multiple that CSL is trading at now of around 40, and I don't see why not, then that doubles the share price target to around $300/share. The only question is - how many years before we get there? How long do we expect to get through PhIII trials on all 4 treatments of 2591, and approved and marketed and achieving significant global market penetration? 10 years or so?
Share Price, page-8582
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.200(1.03%) |
Mkt cap ! $2.466B | |||
| Open | High | Low | Value | Volume |
| $19.50 | $19.59 | $19.11 | $5.729M | 296.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 259 | $19.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.31 | 640 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |